The magnitude and sustainability of treatment benefit of zuranolone on function and well-being as assessed by the SF-36 in adult patients with MDD and PPD: An integrated analysis of 4 randomized clinical trials
Title:
The magnitude and sustainability of treatment benefit of zuranolone on function and well-being as assessed by the SF-36 in adult patients with MDD and PPD: An integrated analysis of 4 randomized clinical trials
Author:
Clayton, Anita H. Suthoff, Ellison Jain, Rakesh Kosinski, Mark Fridman, Moshe Deligiannidis, Kristina M. Meltzer-Brody, Samantha Chen, Shih-Yin Gervitz, Leon Huang, Ming-Yi Trivedi, Madhukar Bonthapally, Vijayveer